Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tonix Pharm Holdings (NQ: TNXP )

0.1393 -0.0060 (-4.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tonix Pharm Holdings

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
BBY Stock Alert: Why Best Buy Investors Are Getting Battered Today
Best Buy (BBY) stock is taking a beating on Tuesday despite the company beating estimates in its most recent earnings report. 
Via InvestorPlace
FDA Clears Tonix Pharma's Human Trial With Intranasal Oxytocin For Migraine
The FDA has signed off Tonix Pharmaceuticals Holding Corp's (NASDAQ: TNXP) Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for... 
Via Benzinga
Exposures Product Safety
TNXP Stock Alert: The Migraine News Sending Tonix Pharmaceuticals Soaring
TNXP stock is soaring 20% on Tuesday after Tonix Pharmaceuticals' treatment for migraines received a key FDA clearance. 
Via InvestorPlace
Exposures Product Safety
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Synlogic Presents Positive Phase 2 Data For Synthetic Biologic Treatment In... 
Via Benzinga
Exposures COVID-19 Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 157.46% to $5.69 during Tuesday's pre-market session. The company's market cap stands at $75.1... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investors! We're getting right back to the grind today with a dive into the biggest pre-market stock movers for Tuesday. 
Via InvestorPlace
Exposures COVID-19 Product Safety
21 Stocks Moving In Tuesday's Pre-Market Session
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 201% to $4.00 in pre-market trading. The company filed proxy statement for annual meeting after the market close on... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Qualigen Therapeutics (NASDAQ:QLGN 
Via Benzinga
Why Tonix Pharmaceuticals Holding Zoomed Higher Today
The company secures a potentially crucial piece of intellectual property. 
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Medpace Hldgs (NASDAQ:MEDP) shar... 
Via Benzinga
3 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins
Via FinancialNewsMedia
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
Tonix Pharma Shares FDA Response For COVID-19 Vaccine Candidate Human Study
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) announced that it received the official written response from a Type B pre-Investigational New Drug (IND) meeting... 
Via Benzinga
Exposures COVID-19 Product Safety
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
Why AMC, Clover, and Other Meme Stocks Are Tumbling Today
The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock's value. And, at... 
Via The Motley Fool
Why Meme Stocks GameStop, Naked, and Tonix Were on the Move Today
The stocks have been active ever since the FDA announced full approval of a COVID-19 vaccine. 
Via The Motley Fool
Exposures COVID-19 Product Safety
Why Shares of GameStop, Naked Brand Group, and Tonix Pharmaceuticals Were Soaring Today
The positive vaccine news seems to have kick-started meme stocks again. 
Via The Motley Fool
Why Shaes of GameStop, Naked Brand Group, and Tonix Pharmaceuticals Were Soaring Today
The positive vaccine news seems to have kick-started meme stocks again. 
Via The Motley Fool
Vaccine Victory
Monday the US stock market moved into further robust mode fueled by official FDA approval of the Pfizer and BioNTech COVID-19 vaccines. Will the momentum last through to Thursday when the Fed's Jackson... 
Via Talk Markets
Topics Economy
Exposures COVID-19 Interest Rates Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
Tonix Pharmaceuticals To Start Mid-Stage Long COVID Trial In Q4
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) received the official minutes from a Type B pre-Investigational New Drug Application (IND) meeting with the FDA.... 
Via Benzinga
Why Meme Stocks AMC, GameStop, and Tonix Rocketed Higher Today
Monday's coronavirus vaccine news was a real shot in the arm for the trio. 
Via The Motley Fool
Exposures COVID-19
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
Exposures Product Safety
Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks?
If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the... 
Via Talk Markets
Exposures Product Safety
Why Meme Stocks Like AMC and GameStop Were All Over the Place Today
Rumors, lingering sentiment, and news about peers appeared to be driving the movements of four popular titles on Thursday. 
Via The Motley Fool
Topics Electric Vehicles
Exposures Electric Vehicles
What's Next for Robinhood Favorite Tonix Pharmaceuticals?
The small drugmaker is moving forward after disappointing clinical results. 
Via The Motley Fool
California and NYC Order Mandatory COVID-19 Testing Among Municipal Workers
Via FinancialNewsMedia
Exposures COVID-19
Is There Any Hope for Tonix Pharmaceuticals Stock?
Yes, but it's looking like a long shot. 
Via The Motley Fool
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback